Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MAGNA Magnesium Glycinate is an oral dietary supplement developed by MAGNA Pharmaceuticals to address magnesium deficiency and support general wellness. The product contains magnesium chelated with the amino acid glycine, a form specifically selected for its high bioavailability and gastrointestinal tolerability. Magnesium is an essential mineral that serves as a cofactor for more than 600 enzymatic reactions, including those responsible for protein synthesis, muscle and nerve function, blood glucose control, and blood pressure regulation. By providing a concentrated source of this mineral, the supplement supports neuromuscular function, bone health, and cardiovascular stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MAGNA Magnesium Glycinate.